×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TVRD – tvardi therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TVRD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
10:28 am
tvrd
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/3
09:50 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Medium
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/30
09:46 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Medium
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/29
08:51 am
tvrd
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Medium
Report
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/25
01:58 pm
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
11/21
10:08 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/20
02:36 pm
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/18
01:22 pm
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Action
From
To
Firm
Impact
%Chg
10/14
09:12 am
Downgrades
Outperform
Market Perform
Raymond James Financial, Inc.
Medium
Report
4.6%
Date
Time
Symbol
Headline
Impact
11/19
06:44 am
tvrd
Form 8-K Tvardi Therapeutics, For: Nov 19
Low
Report
Form 8-K Tvardi Therapeutics, For: Nov 19
11/14
05:03 pm
tvrd
Form SCHEDULE 13G/A Tvardi Therapeutics, Filed by: DePinho Ronald A
Neutral
Report
Form SCHEDULE 13G/A Tvardi Therapeutics, Filed by: DePinho Ronald A
10/20
07:02 pm
tvrd
Form S-8 Tvardi Therapeutics,
Medium
Report
Form S-8 Tvardi Therapeutics,
10/20
05:29 pm
tvrd
Form S-1/A Tvardi Therapeutics,
Medium
Report
Form S-1/A Tvardi Therapeutics,
10/14
06:11 am
tvrd
Form 8-K Tvardi Therapeutics, For: Oct 13
Medium
Report
Form 8-K Tvardi Therapeutics, For: Oct 13
10/7
04:32 pm
tvrd
Form S-1/A Tvardi Therapeutics,
Low
Report
Form S-1/A Tvardi Therapeutics,
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: